Patients with AJCC Stage IIB and III melanoma have a poor 5-year survival rate which has been the driving force behind attempts to find an effective adjuvant therapy for this stage of disease that would effectively reduce relapse and improve survival. Immunotherapy with bacillus Calmette-Guerin (BCG
โฆ LIBER โฆ
The role of adjuvant therapy in melanoma management
โ Scribed by Andreas Barth; Donald L. Morton
- Publisher
- John Wiley and Sons
- Year
- 1995
- Tongue
- English
- Weight
- 912 KB
- Volume
- 75
- Category
- Article
- ISSN
- 0008-543X
No coin nor oath required. For personal study only.
๐ SIMILAR VOLUMES
Adjuvant therapy of melanoma
โ
Sanjiv S. Agarwala; John M. Kirkwood
๐
Article
๐
1998
๐
John Wiley and Sons
๐
English
โ 59 KB
๐ 1 views
Interferon adjuvant therapy of melanoma
โ
Larry Nathanson
๐
Article
๐
1996
๐
John Wiley and Sons
๐
English
โ 344 KB
๐ 2 views
Interferon adjuvant therapy of melanoma
โ
John M. Kirkwood; David Wazer; Maury Rosenstein
๐
Article
๐
1997
๐
John Wiley and Sons
๐
English
โ 58 KB
๐ 1 views
The role of chemotherapy and adjuvant th
โ
Walter B. Forman
๐
Article
๐
1994
๐
John Wiley and Sons
๐
English
โ 256 KB
๐ 3 views
This review of the current literature related to the use of chemo-and adjuvant chemotherapy in colorectal carcinoma emphasizes the present dilemma in caring for people affected with this disorder. Adjuvant chemotherapy using combinations of 5-fluorouracil and levamisole clearly prolong survival, alb
Current management of melanoma: Benefits
โ
Kelly M. McMasters; Susan M. Swetter
๐
Article
๐
2003
๐
John Wiley and Sons
๐
English
โ 97 KB
Adjuvant chemotherapy in the management
โ
Prof. Pierre Banzet; Claude Jacquillat; Jean Civatte; Antoine Puissant; Jean Mar
๐
Article
๐
1978
๐
John Wiley and Sons
๐
English
โ 507 KB